These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32848035)

  • 1. Intracellular Galectin-3 Is Essential for OX40-Mediated Memory CD8
    Amani MF; Rolig AS; Redmond WL
    J Immunol; 2020 Oct; 205(7):1857-1866. PubMed ID: 32848035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual anti-OX40/IL-2 therapy augments tumor immunotherapy via IL-2R-mediated regulation of OX40 expression.
    Redmond WL; Triplett T; Floyd K; Weinberg AD
    PLoS One; 2012; 7(4):e34467. PubMed ID: 22496812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defects in the acquisition of CD8 T cell effector function after priming with tumor or soluble antigen can be overcome by the addition of an OX40 agonist.
    Redmond WL; Gough MJ; Charbonneau B; Ratliff TL; Weinberg AD
    J Immunol; 2007 Dec; 179(11):7244-53. PubMed ID: 18025166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses.
    Ruby CE; Redmond WL; Haley D; Weinberg AD
    Eur J Immunol; 2007 Jan; 37(1):157-66. PubMed ID: 17183611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligation of the OX40 co-stimulatory receptor reverses self-Ag and tumor-induced CD8 T-cell anergy in vivo.
    Redmond WL; Gough MJ; Weinberg AD
    Eur J Immunol; 2009 Aug; 39(8):2184-94. PubMed ID: 19672905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous OX40 stimulation during lymphocytic choriomeningitis virus infection impairs follicular Th cell differentiation and diverts CD4 T cells into the effector lineage by upregulating Blimp-1.
    Boettler T; Choi YS; Salek-Ardakani S; Cheng Y; Moeckel F; Croft M; Crotty S; von Herrath M
    J Immunol; 2013 Nov; 191(10):5026-35. PubMed ID: 24101548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OX40 costimulatory signals potentiate the memory commitment of effector CD8+ T cells.
    Mousavi SF; Soroosh P; Takahashi T; Yoshikai Y; Shen H; Lefrançois L; Borst J; Sugamura K; Ishii N
    J Immunol; 2008 Nov; 181(9):5990-6001. PubMed ID: 18941188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OX40 ligation of CD4+ T cells enhances virus-specific CD8+ T cell memory responses independently of IL-2 and CD4+ T regulatory cell inhibition.
    Yu Q; Yue FY; Gu XX; Schwartz H; Kovacs CM; Ostrowski MA
    J Immunol; 2006 Feb; 176(4):2486-95. PubMed ID: 16456009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo.
    De Smedt T; Smith J; Baum P; Fanslow W; Butz E; Maliszewski C
    J Immunol; 2002 Jan; 168(2):661-70. PubMed ID: 11777959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of A1 by OX40 contributes to CD8(+) T cell survival and anti-tumor activity.
    Lei F; Song J; Haque R; Haque M; Xiong X; Fang D; Croft M; Song J
    PLoS One; 2013; 8(8):e70635. PubMed ID: 23936461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
    Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
    J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. During viral infection of the respiratory tract, CD27, 4-1BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion.
    Hendriks J; Xiao Y; Rossen JW; van der Sluijs KF; Sugamura K; Ishii N; Borst J
    J Immunol; 2005 Aug; 175(3):1665-76. PubMed ID: 16034107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T-cell anergy and promotes survival in tumor-bearing mice.
    Linch SN; Kasiewicz MJ; McNamara MJ; Hilgart-Martiszus IF; Farhad M; Redmond WL
    Proc Natl Acad Sci U S A; 2016 Jan; 113(3):E319-27. PubMed ID: 26729864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential requirements for OX40 signals on generation of effector and central memory CD4+ T cells.
    Soroosh P; Ine S; Sugamura K; Ishii N
    J Immunol; 2007 Oct; 179(8):5014-23. PubMed ID: 17911586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion.
    Gramaglia I; Jember A; Pippig SD; Weinberg AD; Killeen N; Croft M
    J Immunol; 2000 Sep; 165(6):3043-50. PubMed ID: 10975814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An alternative signal 3: CD8⁺ T cell memory independent of IL-12 and type I IFN is dependent on CD27/OX40 signaling.
    Sanchez PJ; Kedl RM
    Vaccine; 2012 Feb; 30(6):1154-61. PubMed ID: 22178730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses.
    Dawicki W; Bertram EM; Sharpe AH; Watts TH
    J Immunol; 2004 Nov; 173(10):5944-51. PubMed ID: 15528328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined targeting of costimulatory (OX40) and coinhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust antitumor immunity.
    Redmond WL; Linch SN; Kasiewicz MJ
    Cancer Immunol Res; 2014 Feb; 2(2):142-53. PubMed ID: 24778278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple levels of activation of murine CD8(+) intraepithelial lymphocytes defined by OX40 (CD134) expression: effects on cell-mediated cytotoxicity, IFN-gamma, and IL-10 regulation.
    Wang HC; Klein JR
    J Immunol; 2001 Dec; 167(12):6717-23. PubMed ID: 11739485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OX40-mediated differentiation to effector function requires IL-2 receptor signaling but not CD28, CD40, IL-12Rbeta2, or T-bet.
    Williams CA; Murray SE; Weinberg AD; Parker DC
    J Immunol; 2007 Jun; 178(12):7694-702. PubMed ID: 17548606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.